Only one study by Aarnio et al. (1999) included in our meta-analysis defined kidney cancer as renal-cell adenocarcinoma (particularly amongst MLH1 mutation carriers), whereas the remaining two studies were unspecified kidney/renal masses. The gene discussed is MLH1; the disease is kidney cancer.